Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes – PR Newswire (press release)
 The Money Times |
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
PR Newswire (press release) Immunogenicity-related events, including urticaria, were more common among Victoza-treated patients than among comparator-treated patients in clinical … Liraglutide approved for type 2 diabetesTheHeart.Org FDA Approves Once-Daily LiraglutideMedPage Today all 415 news articles » |
